期刊文献+

P38MAPK的激活上调SH-SY5Y细胞APP表达及组蛋白H3乙酰化水平

P38MAPK activation up-regulates the level of APP expression and histone H3 acetylation
下载PDF
导出
摘要 目的研究P38MAPK信号通路的激活对淀粉前体蛋白(APP)表达的影响及其相关表观遗传学机制。方法体外培养神经母细胞瘤细胞(SH-SY5Y),Western blot法检测SH-SY5Y的APP蛋白表达及组蛋白乙酰化酶(HAT)和组蛋白去乙酰化酶(HDAC)的表达;吸光度值法检测组蛋白3(H3)和组蛋白4(H4)整体乙酰化水平。结果 P38MAPK信号通路经特异性激动剂激活SH-SY5Y 72 h后,APP表达明显增高至对照组的1.5倍(0.41±0.09vs0.28±0.08,P<0.01);同时组蛋白H3整体乙酰化水平增高(0.20±0.04vs0.06±0.03,P<0.01),但H4乙酰化水平无明显改变;组蛋白乙酰化酶CBP表达增高至对照组的2.5倍(0.30±0.03vs0.11±0.05,P<0.01),而组蛋白去乙酰化酶HDAC3表达下降至对照组的40%(0.19±0.05vs0.49±0.03,P<0.01)。结论 P38MAPK信号通路可能通过上调组蛋白乙酰化水平增加SH-SY5Y的APP蛋白表达。 Objective To investigate the role of P38MAPK in the expression of β-Amyloid precursor protein(APP) and it's epigenetic mechanisms.Methods Cultured SH-SY5Y cells were used to test the expression of APP,histone acetyltranferase(HAT) and histone deacetyltranferase(HDAC) by Western blot after activation of P38MAPK;Acetylation level of histone H3 and H4 were examined by optical density assay.Results APP expression was increased after P38MAPK activation for 72 hours compared to the control(0.41±0.09 vs 0.28±0.08,P〈0.01).Level of histone H3 acetylation was increased(0.20±0.04 vs 0.06±0.03,P〈0.01)accompanied with up-regulation of CBP(0.30±0.03 vs 0.11±0.05,P〈0.01) and down-regulation of HDAC3(0.19±0.05 vs 0.49±0.03,P〈0.01).Conclusion APP expression on SH-SY5Y cells may increase through up-regulation of histone acetylation through P38MAPK pathway.
出处 《基础医学与临床》 CSCD 北大核心 2011年第9期984-987,共4页 Basic and Clinical Medicine
基金 北京市自然科学基金(7102012)
关键词 P38MAPK 组蛋白乙酰化 淀粉前体蛋白 阿尔茨海默病 P38MAPK histone acetylation β-amyloid precursor protein Alzheimer's disease
  • 相关文献

参考文献14

  • 1Francis YI,FM,Ashraf Het al.Dysregulation of his-tone acetylation in the APP/PS1 mouse model ofAlzheimer s disease. Journal of Alzheimer s Disease . 2009
  • 2Wirths O,Breyhan H,Marcello Aet al.Inflammatorychanges are tightly associated with neurodegeneration inthe brain and spinal cord of the APP/PS1KI mouse modelof Alzheimer s disease. Neurobiology of Aging . 2008
  • 3Chouliaras L,Rutten BP,Kenis Get al.Epigenetic reg-ulation in the pathophysiology of Alzheimer s disease. Progress in Neurobiology . 2010
  • 4Peers C,,Dallas ML,Boycott HE, et al.Hypoxia and neurodegeneration. Annals of the New York Academy of Sciences . 2009
  • 5M Guglielmotto,M Aragno,R Autelli,L Giliberto,E Novo,S Colombatto,O Danni,M Parola,MA Smith,G Perry,E Tamagno,M Tabaton.The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α. Journal of Neurochemistry . 2009
  • 6Barry O P,Kazanietz M G,Pratico D,etal.Arachidonic acid in plateletmicroparticles up-regulates cyclooxy-genase-2-dependent prostaglandin for-mation via a protein kinaseC/mitogen-activated protein kinase-dependentpathway. Journal of Biological Chemistry . 2000
  • 7Graff J,Mansuy I M.Epigenetic dysregulation in cognitive disorders. European Journal of Neuroscience . 2009
  • 8Wu J,Basha MR,Zawia NH.The environment,epigenetics andamyloidogenesis. Journal of molecular neu-roscience:MN . 2008
  • 9A Mai,D Rotili,S Valente,AG Kazantsev.Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise. Current Pharmaceutical Design . 2009
  • 10Tamagno E,Parola M,Bardini P. et al.Beta-site APP cleaving enzyme up-regulation induced by 4-hydr- oxynonenal is mediated by stress-activated protein kinases pathways. Journal of Neurochemistry . 2005

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部